Tranexamic acid for haemostasis and beyond: does dose matter?

Abstract Tranexamic acid (TXA) is a widely used antifibrinolytic agent that has been used since the 1960’s to reduce blood loss in various conditions. TXA is a lysine analogue that competes for the lysine binding sites in plasminogen and tissue-type plasminogen activator impairing its interaction wi...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Tammy Lam, Robert L. Medcalf, Geoffrey C. Cloud, Paul S. Myles, Charithani B. Keragala
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2023-09-01
Цуврал:	Thrombosis Journal
Нөхцлүүд:	Tranexamic acid Fibrinolysis Thrombosis Immunity Amyloid Pharmacology
Онлайн хандалт:	https://doi.org/10.1186/s12959-023-00540-0
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!